Skip to content
healthcare.dev

Creon

NDC 0032-0046, Pancrelipase, capsule, delayed release pellets, from AbbVie Inc..

Product NDC
0032-0046
Status
Listed
Labeler
AbbVie Inc.
Dosage form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA020725
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0032-0046 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PANCRELIPASE AMYLASE30000 [USP'U]/1
  • PANCRELIPASE LIPASE6000 [USP'U]/1
  • PANCRELIPASE PROTEASE19000 [USP'U]/1
Package NDCNDC-11Package
0032-0046-3000032004630100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-0046-30)
0032-0046-7000032004670100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-0046-70)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/073201aa-556d-4a70-918e-84e9616fd88d
  • NADAC price for package 00032004670

    GET /v1/drugs/nadac/00032004670

Use it

Look up 0032-0046 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0032-0046 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0032-0046. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.